Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamons cell carcinoma

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We report on the influences of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects associated with low dose sequential methotrexate (MTX) and 5-fluorouracil (5-FU) (MF therapy) as neo-adjuvant chemotherapy in oral cancer. The oval cancer of 22 patients was treated as follows: MTX (75 mg/body) was administrated by intravenous infusion for 1 hour, followed by 5-FU (500 mg/body) intravenous infusion for 2 hours on Day 1, MTX (75 mg/body) intravenous infusion for 1 hour on Day 4, and parenteral dose of leucovorin on Day 2 and Day 5. The MF therapy of 1-5 courses was performed weekly or every 2 week. The clinical response rate was lower in stage IV than in the other stages. There was no difference in the rate of tumor differentiation by WHO grade classification I and II. The rate was higher in grade 1, 2 and 3 than in grade 4C and 4D due to mode of invasion. The histological response rate was higher in stage I and II than in stage III and IV. The response rate was higher in grade II than in grade I, but was higher in grade 1 and 2 than in grade 3 and 4C. However the response rate in grade 4D was good (66.7%; 2/3). Histological response was demonstrated only in partial or complete response cases of the clinical response. MF therapy was suggested to be effective for histological response regardless of stage classification, tumor differentiation and mode of invasion although its success rate was low in stage III, IV (stage classification), grade I (tumor differentiation), grade 3 and 4C (mode of invasion).

Original languageEnglish
Pages (from-to)147-151
Number of pages5
JournalIn Vivo
Volume11
Issue number2
Publication statusPublished - Mar 1997

Fingerprint

Chemotherapy
Adjuvant Chemotherapy
Methotrexate
Fluorouracil
Tumors
Cells
Carcinoma
Intravenous Infusions
Neoplasms
Leucovorin
Mouth Neoplasms
Therapeutics

Keywords

  • Histopathological effect
  • Mode of invasion
  • Neo-adjuvant chemotherapy
  • Oral squamous cell carcinoma
  • Sequential methotrexate and 5-fluorouracil

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{721739931429476c816da5efc11b48d1,
title = "Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamons cell carcinoma",
abstract = "We report on the influences of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects associated with low dose sequential methotrexate (MTX) and 5-fluorouracil (5-FU) (MF therapy) as neo-adjuvant chemotherapy in oral cancer. The oval cancer of 22 patients was treated as follows: MTX (75 mg/body) was administrated by intravenous infusion for 1 hour, followed by 5-FU (500 mg/body) intravenous infusion for 2 hours on Day 1, MTX (75 mg/body) intravenous infusion for 1 hour on Day 4, and parenteral dose of leucovorin on Day 2 and Day 5. The MF therapy of 1-5 courses was performed weekly or every 2 week. The clinical response rate was lower in stage IV than in the other stages. There was no difference in the rate of tumor differentiation by WHO grade classification I and II. The rate was higher in grade 1, 2 and 3 than in grade 4C and 4D due to mode of invasion. The histological response rate was higher in stage I and II than in stage III and IV. The response rate was higher in grade II than in grade I, but was higher in grade 1 and 2 than in grade 3 and 4C. However the response rate in grade 4D was good (66.7{\%}; 2/3). Histological response was demonstrated only in partial or complete response cases of the clinical response. MF therapy was suggested to be effective for histological response regardless of stage classification, tumor differentiation and mode of invasion although its success rate was low in stage III, IV (stage classification), grade I (tumor differentiation), grade 3 and 4C (mode of invasion).",
keywords = "Histopathological effect, Mode of invasion, Neo-adjuvant chemotherapy, Oral squamous cell carcinoma, Sequential methotrexate and 5-fluorouracil",
author = "Jun-Ichi Asaumi",
year = "1997",
month = "3",
language = "English",
volume = "11",
pages = "147--151",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamons cell carcinoma

AU - Asaumi, Jun-Ichi

PY - 1997/3

Y1 - 1997/3

N2 - We report on the influences of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects associated with low dose sequential methotrexate (MTX) and 5-fluorouracil (5-FU) (MF therapy) as neo-adjuvant chemotherapy in oral cancer. The oval cancer of 22 patients was treated as follows: MTX (75 mg/body) was administrated by intravenous infusion for 1 hour, followed by 5-FU (500 mg/body) intravenous infusion for 2 hours on Day 1, MTX (75 mg/body) intravenous infusion for 1 hour on Day 4, and parenteral dose of leucovorin on Day 2 and Day 5. The MF therapy of 1-5 courses was performed weekly or every 2 week. The clinical response rate was lower in stage IV than in the other stages. There was no difference in the rate of tumor differentiation by WHO grade classification I and II. The rate was higher in grade 1, 2 and 3 than in grade 4C and 4D due to mode of invasion. The histological response rate was higher in stage I and II than in stage III and IV. The response rate was higher in grade II than in grade I, but was higher in grade 1 and 2 than in grade 3 and 4C. However the response rate in grade 4D was good (66.7%; 2/3). Histological response was demonstrated only in partial or complete response cases of the clinical response. MF therapy was suggested to be effective for histological response regardless of stage classification, tumor differentiation and mode of invasion although its success rate was low in stage III, IV (stage classification), grade I (tumor differentiation), grade 3 and 4C (mode of invasion).

AB - We report on the influences of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects associated with low dose sequential methotrexate (MTX) and 5-fluorouracil (5-FU) (MF therapy) as neo-adjuvant chemotherapy in oral cancer. The oval cancer of 22 patients was treated as follows: MTX (75 mg/body) was administrated by intravenous infusion for 1 hour, followed by 5-FU (500 mg/body) intravenous infusion for 2 hours on Day 1, MTX (75 mg/body) intravenous infusion for 1 hour on Day 4, and parenteral dose of leucovorin on Day 2 and Day 5. The MF therapy of 1-5 courses was performed weekly or every 2 week. The clinical response rate was lower in stage IV than in the other stages. There was no difference in the rate of tumor differentiation by WHO grade classification I and II. The rate was higher in grade 1, 2 and 3 than in grade 4C and 4D due to mode of invasion. The histological response rate was higher in stage I and II than in stage III and IV. The response rate was higher in grade II than in grade I, but was higher in grade 1 and 2 than in grade 3 and 4C. However the response rate in grade 4D was good (66.7%; 2/3). Histological response was demonstrated only in partial or complete response cases of the clinical response. MF therapy was suggested to be effective for histological response regardless of stage classification, tumor differentiation and mode of invasion although its success rate was low in stage III, IV (stage classification), grade I (tumor differentiation), grade 3 and 4C (mode of invasion).

KW - Histopathological effect

KW - Mode of invasion

KW - Neo-adjuvant chemotherapy

KW - Oral squamous cell carcinoma

KW - Sequential methotrexate and 5-fluorouracil

UR - http://www.scopus.com/inward/record.url?scp=0030902849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030902849&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 147

EP - 151

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 2

ER -